Table 2.
AEs
| Variable | Cohort 1 (2.0 × 1011 vg/kg) | Cohort 2 (1.0 × 1012 vg/kg) | Cohort 3 (3.0 × 1012 vg/kg) | |||||
|---|---|---|---|---|---|---|---|---|
| Participant no. | 1 | 2 | 3 | 4 | 5 | 8 | 6 | 7 |
| AE possibly related to BAX 335, n | 1 | 6 | 0 | 0 | 0 | 2 | 1 | 0 |
| SAE unrelated* to BAX 335, n | 1 | NA | 0 | 2 | 0 | 1 | 0 | 0 |
| AEs possibly related to BAX 335, description (severity) | Tiredness (mild) |
|
NA | NA | NA |
|
Elevated liver enzyme levels (mild) | NA |
| SAEs unrelated* to BAX 335, description (severity) | Exercise-induced rhabdomyolysis (severe) | NA | NA | Bacterial infection of right tonsil (moderate)Tonsillar hemorrhage (moderate) | NA | Tonsillar carcinoma (severe) | NA | NA |
NA, not applicable.
No SAEs were considered related to BAX 335 treatment.